Pharmaceutical equipment market development prospects analysis:
Source: Xiangyu Pharmaceutical to learn more enter http://www.shanghaixiangyu.com
In recent years, with the acceleration of drug approval, the promotion of generic drug consistency evaluation, drug procurement, medical insurance catalogue adjustment and other pharmaceutical new policies, the transformation and upgrading of China's pharmaceutical industry has accelerated, while the biologic pharmaceutical industry represented by monoclonal antibody, double antibody and ADC has flourished, bringing new opportunities and challenges to the upstream pharmaceutical equipment industry. Since 2020, domestic pharmaceutical machines have seized the huge space of import substitution, and their market share has gradually increased. So, how will China's pharmaceutical equipment market develop in the next few years? What are the trends?
Pharmaceutical equipment includes: granulation oven, boiling dryer, wet machine, crusher, vibrating screen, slicer, stir-frying machine, medicine machine, tablet press, pill making machine, multifunctional extraction tank, liquid storage tank, liquid dispensing tank, vacuum drying oven, tilting reaction pot, capsule filling machine, blister packaging machine, pellet packaging machine, powder packaging machine, V-type mixer, lifting feeder and so on.
The upstream industries of pharmaceutical equipment mainly include steel, mechanical parts and electrical parts industries. The steel industry provides various types of steel for the pharmaceutical equipment industry, for the production of pharmaceutical equipment brackets, main structural parts and non-standard mechanical parts: mechanical and electrical parts for the pharmaceutical equipment industry to provide a variety of standard mechanical parts and electrical parts such as motors, pneumatic components, PLC modules; The downstream demand customers of the pharmaceutical equipment industry are mainly pharmaceutical enterprises, and pharmaceutical equipment is one of the most basic facilities of pharmaceutical enterprises.
The downstream demand for pharmaceutical equipment is mainly for the pharmaceutical industry, including the chemical raw material industry, the chemical preparation industry, traditional Chinese medicine pieces and the biopharmaceutical industry. At present, the demand for chemical preparations is the largest, and the demand for midstream pharmaceutical equipment is the largest, while the demand for traditional Chinese medicine pieces has the greatest potential.
The pharmaceutical industry is an important part of China's national economy. China's pharmaceutical industry has maintained rapid growth, especially with the acceleration of the process of medical reform, the growth of medical insurance investment and the improvement of national medical and health awareness, the scale has been expanding, and the quality and efficiency of economic operation have been continuously improved. "China Pharmaceutical Equipment Industry Market Demand Forecast and Investment strategic planning Analysis Report" The total industrial output value of the national pharmaceutical industry reached 1,443.799 billion yuan; The sales revenue was 1,452.205 billion yuan, up 29.37% year on year.
With the development of pharmaceutical industry, China's pharmaceutical equipment industry has also maintained rapid growth. The data show that the sales revenue of China's pharmaceutical equipment industry increased year by year, reaching 7.661 billion yuan, an increase of 9.79%.
According to the "2022-2026 Pharmaceutical equipment market status survey and development prospects Analysis Report" released by Hangzhou Zhongjing Zhisheng Market Research Co., LTD., the first is in pharmaceutical safety, the "Twelfth Five-Year Development Plan of the National pharmaceutical Industry" proposed to fully implement the new version of GMP, and strictly implement GMP, significantly improve the overall level of drug quality management in China. Encourage qualified enterprises to carry out GMP certification in developed countries or WHO, and drive China's drug quality management to be in line with international standards; The European Union (EU) officially issued Directive 62/EU, raising the import threshold of medicines.
The EU is China's largest export market for chemical pharmaceutical products, according to the analysis, from the data, I exported Western pharmaceutical products to Europe of 6 billion US dollars, an increase of 18%, accounting for 25% of the global market. Although the latest GMP standard implemented in China covers the basic requirements of the EU, the US FDA and the WHO for GMP, in which the hardware refers to the EU standard, the software refers to the US FDA standard, its strictest degree is unprecedented in the history of Chinese pharmaceutical industry, but in the Chinese pharmaceutical export enterprises, There are only a few large enterprises with GMP recognition from both China and the EU, so the promulgation of the new standard will certainly cause the production transformation and upgrading of export enterprises to accelerate.
Under the background of the introduction of the new version of GMP standards in the EU, the full implementation of the new version of GMP in China and the improvement of pharmaceutical environmental protection requirements, the growth rate of the future API equipment market capacity will be better, on the one hand, the proportion of apis in Western medicines exported to the EU market is about 50%, the proportion is larger; On the other hand, apis are the most environmentally polluting modules in pharmaceutical companies, so their environmental input needs are also greater.
From the perspective of the chemical preparations market, the total industrial production value of China's chemical preparations shows an increasing trend year by year. According to statistics, the main business income of the chemical pharmaceutical preparation industry in 2019 totaled 857.6 billion yuan, an increase of 11.5%. The main business income of the chemical pharmaceutical preparation industry reached 835.7 billion yuan.
In recent years, China has continuously introduced policies to support the development of the pharmaceutical equipment industry, encouraging the development and production of high-end pharmaceutical equipment, new preparation production equipment such as transdermal absorption and powder aerosol, large-scale bioreactors and affiliated systems, efficient separation and purification equipment for proteins, efficient extraction equipment for traditional Chinese medicine, and continuous production technology and equipment for drugs. Continue to promote the digitalization process of the pharmaceutical industry, empower pharmaceutical manufacturing with a new generation of information technology, and improve the automation, digitalization, and intelligence level of pharmaceutical equipment. Due to the favorable policies of the pharmaceutical industry and the pharmaceutical industry, the development of the entire pharmaceutical equipment industry has also ushered in new development opportunities, and the prospect is bright.
Learn more：http://www.shanghaixiangyu.com